On supporting science journalism
If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.
Snapshots of our brain in action reveal its form and function, from molecules and cells to the grand orchestration of complex systems. The multidisciplinary symposium What Do We Want to See in Brain Imaging? will highlight recent technological achievements as attendees explore the potential for neuroimaging to revolutionize our understanding of the mind.
12/3 & 12/4 - London
http://edab.dana.org/brain-imaging_en.cfm
On this day in 1955 the U.S. Food and Drug Administration approved the stimulant methylphenidate—sold as Ritalin—for the treatment of ailments such as depression, chronic fatigue and narcolepsy. During the 1960s the drug was found to help people with “hyperkinetic syndrome,” known today as attention-deficit hyperactivity disorder (ADHD) and now widely diagnosed in children. Recent experiments indicate that Ritalin may work by boosting levels of dopamine in the brain, helping to focus attention. 12/5
Subscribe to Support Independent Journalism
Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.
When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.
Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber
